mardi 5 juin 2018

Onco Actu du 5 juin 2018

2.7 Etiologie - Obésité

How much cancer stems from diabetes, obesity? Lancet journal swaps high-profile paper [Retraction Watch]

3.5 Prévention - UV

Britons 'risking skin damage and cancer due to SPF ignorance' [The Guardian]

4.13 Dép., diag. & prono. - Peau

Yes, melanoma can be overdiagnosed, but news stories like these don’t discuss it [HealthNewsReview]

4.9 Dép., diag. & prono. - Sein

Breast screening errors may have led to 74 premature deaths [The Guardian]

5. Traitements

Marketing personalized cancer treatments requires careful language [Nature]

5.12 Immunothérapies

A new cancer care dilemma: Patients want immunotherapy even when evidence is lacking [STAT]

5.12.2 Immunothérapies - CAR-T

FDA Grants Cellectis IND Approval for UCART22 in B-ALL [Cellectis]

5.12.3 Immunothérapies-combinaisons

The difficult search for the right recipe in cancer immunotherapy [C&EN]

5.12.6 Immunothérapies - AMM

EMA recommends restrictions on Merck, Roche immunotherapies [Reuters]

5.2 Pharma

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA™ (trastuzumab) [Pfizer]

5.2.1 Pharma - Partenariats

With competition on its heels, Blueprint takes three cancer drugs to China [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed modernization of FDA’s drug review office [FDA]

FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan [EndPoints]

5.3.4 Traitements - AMM (FDA, EMA,...)

FDA approves first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment [FDA]

European Commission approves Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence [Roche]

Roche's Perjeta wins approval in Europe for expanded use [Reuters]

6.1 Observation

NHS cancer patients 'failing to be correctly monitored' [The Guardian]

6.11 Patients

No chemo: the test that made me a lucky breast cancer patient | Joanna Moorhead [The Guardian]

6.6 Publications

Building the UK ORCID consortium [JISC]

6.7.2 Applis

Apple is giving medical researchers and app developers new ways to prevent diseases [CNBC]

6.9 Controverses

Learning The Right Lesson From Theranos: Fraud Is Bad, Wanting To Disrupt Healthcare Isn't [Forbes]